China's Sinopharm To Diversify Into Hospital Business By Buying Stakes
This article was originally published in PharmAsia News
Executive Summary
China's largest drug distributor, Sinopharm Group, plans to enter the hospital business, beginning with a $381 million acquisition this year and several more in 2014.